Stereotactic Intracerebral Injection of IPSC-DAPs in Patients with Parkinson's Disease

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

September 30, 2026

Conditions

Parkinson Disease

Interventions

BIOLOGICAL

ICA07 therapy

4 million iPSC-DAPs will be administrated into the putamen on each side of the brain

Trial Locations (1)

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors

collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

lead

iCamuno Biotherapeutics Ltd.

INDUSTRY